APPLICATIONS PUBLISHED 8 JUNE 2005
Heterocarpin, a plant-derived protein with anti-cancer properties
Societe de Conseils de Recherches et d'Applications Scientifiques 1536808*
Heterocarpin, a plant-derived protein with anti-cancer properties
Societe de Conseils de Recherches et d'Applications Scientifiques 1536808*
Use as fermented wheat germ extract as anti-inflammatory agent
Hidvegi, Mate 1536809*
Extraction of pharmaceutically active cannabinoids from plant materials
GW Pharma 1536810*
Extraction and purification method of active constituents from stem of Lonicera japonica thunb., its usage for anti-inflammatory and analgesic drug
SK Chemicals 1536811*
Methods for modulating activity of the FXR nuclear receptor
City of Hope 1536812*
Compsns and methods comprising protein activated receptor antagonists
EntreMed 1536813*
ANTibodies to non-shed MUC1 and MUC16, and uses thereof
Immunogen 1536814*
Angio-immunotherapy
Duke University 1536815*
Amelioration of effects of cigarette smoke
Witten, Mark; Harris, David 1526816*
Growth hormone-releasing peptides in the treatment of prevention of atherosclerosis and hypercholesterolemia
Gestion Univalor Societe en Commandite 1536817*
Fibrinogen binding moieties
Dyax 1536818*
Use of ROM Production and release inhibitors to treat and prevent intraocular damage
Maxim Pharmaceuticals 1536819*
Cancer therapy using whole glucan particles and antibodies
Biopolymer Engineering; University of Louisville Research Foundation 1536820*
Inhibition of T cell activation by butyrophilin 4 or B7-L1
Wyeth 1536821*
Stable pharmaceutical compsn comprising erythropoietin
LEK Pharmaceuticals DD 1536822*
Use of erythropoietin
F Hoffmann-La Roche 1536823*
Ubiquitin and ubiquitin related molecules for treatment and prevention of harmful activation of the immune system
University of Miami, Office of Technology Transfer; Universitaet Heidelberg 1536824*
Interferon and immunoglobulin FC fragment hybrid
Tanox 1536825*
Thymus-based tolerogenic approaches for type I diabetes
Universite de LiEge 1536826*
Use of protein kinase N beta
Atugen 1536827*
Methods of delivery of exogenous proteins to the cystol and uses thereof
President and Fellows of Harvard College; The General Hospital Corp 1536828*
Methods for preparing compsns comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease
University of Connecticut Health Centre 1536829*
Vaccine for respiratory and reproductive system infections in cattle
Pfizer Products 1356830*
Pharmaceutical liposomal compsns containing N. meningitidis derived polypeptides or polynucleotides
ID Biomedical 1536831*
Flagellin peptides as adjuvants for vaccines
Fondation Eurovacc 1536832*
Vaccine against Yersinia comprising one or two antibodies, one specific for Yersina pestis F1-antigen and the other one for Yersina pestis V-antigen
The Secretary of State for Defence, DSTL Porton Down 1536833*
Design for chemokine analogues for the treatment of human diseases
Chemokine Therapeutics 1536834*
Liquid formulations with high concentration of human growth hormone (HGH) comprising phenol
Sandoz 1536835*
Topical emulsion-gel compsn comprising diclofenac sodium
Novartis Consumer Health 1536836*
Compsn for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
Bio Syntech Canada 1536837*
Conjugated hydroxylakyl starch allergen compounds
Fresenius Kabi Deutschland 1536838*
Method for treating diseases with omega interferon
Intarcia Therapeutics 1536839*
Formulation for inwardly transferring nucleic acids into eukaryotic cells
Avontec 1536840*
Monitoring and diagnosis of gastric emptying and gastroparesis
The University of Chicago 1536841*
Methods for functional kidney imaging using dendrimer conjugate contrast agents
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services 1536842*
Radiolabelled compounds and liposomes and their methods of making and using the same
Board of Regents of the University of Texas System 1536843*
Preparation of M(CO)3-complexes by solid phase techniques via metal assisted cleavage from the solid support
University of Zurich 1536844*
Wound dressing materials comprising complexes of anionic polysaccharides with silver
Johnson & Johnson 1536845*
Active agent delivery system including a polyurethane, medical device, and a method
Medtronic 1536846*
Analogues of vitamin D
Galderma Research & Development 1537065*
Improvements in pharmaceutically useful compounds
Charterhouse Therapeutics 1537066*
Resolvins: biotemplates for therapeutic interventions
Brigham and Women's Hospital 1537067*
Materials and methods for treating hypercholesterolemia
Aryx Therapeutics 1537068*
Analogues of lipid mediators derived from omega-3 pufas and methods of use
Resolvyx Pharmaceuticals 1537069*
Process for preparing nitorxyalkyl substituted estes of carboxylic acids, intermediates useful in said process and preparation thereof
Nicox 1537070*
Method for the production of optically active 2-amino-, 2-chloro-, 2-hydroxy or 2-alkoxy-1-alcohols
BASF 1536071*
Substituted aminoethers for the treatment of Alzheimer's disease
Pharmacia & Upjohn 1537072*
Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
Karo Bio; Bristol-Myers Squibb 1537073*
Cathepsin cysteine protease inhibitors
Merck Frosst Canada 1537074*
Diarylurea derivative and their use as chloride channel blockers
Neurosearch 1537075*
Novel vinyl carboxylic acid derivatives and their therapeutic use
Novo Nordisk 1537076*
4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties
Syngenta Participations 1537077*
Indoles having antidiabetic activity
Merck 1537078*
Phenyl-indole compounds for modulating IGE and inhibiting cellular proliferation
Avanir Pharmaceuticals 1537079*
Substituted spirocyclic ketoenols
Bayer CropScience 1537080*
Dihydropyridine derivatives for use as human neutrophil elastase inhibitors
Bayer HealthCare 1537081*
Processes for the preparation of S-(-)-amlodipene
Hanlim Pharmaceutical 1537082*
S-(-)-amlodipine nicotinate and processes for the preparation thereof
Hanlim Pharmaceuticals 1537083*
Substituted 2-alkylamine nicotinic amide derivatives and use thereof
Amgen 1537084*
Oxytocin inhibitors
Pfizer 1537085*
Novel phenanthridines
Altana Pharma 1537086*
Novel aminoindazole derivatives as medicines and pharmaceutical compsns containing same
Aventis Pharma 1537087*
Compounds, compsns and methods
Cytokinetics 1537089*
Chromone derivatives as matrix metalloproteinase inhibitors
Warner-Lambert 1537090*
Novel 2-arylthiazole compounds as PPARalpha and PPARgamma agonists
F Hoffmann-La Roche 1537091*
Taxane derivatives functionalised at the 14-position and a process for the preparation thereof
Indena 1537093*
Methods and compsns for converting taxane amides to paclitaxel or other taxanes
Natural Pharmaceuticals 1537094*
Process for preparing functionalised butyrolactiones from mucohalic acid
Warner-Lambert 1537095*
Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics
Sanofi-Aventis 1537096*
Method of preparing 3-halo-4,5-dihydro-1 H-pyrazoles
EI du Pont de Nemours 1537097*
Monocyclic derivatives as matrix metalloproteinase inhibitors
Warner-Lambert 1537098*
Pyrrole based inhibitors of glycogen synthase kinase 3
Chiron 1537099*
Pyrrolidinedione substituted piperidine-phthalazones as PDE4 inhibitors
Altana Pharma 1537100*